Skip to main content

Baader Bank Aktiengesellschaft

Bank

Position in BIIB — Biogen Inc.

CIK 1542629 Unterschleissheim, 2M

Position in BIIB

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$6,172,402
+$525,655 QoQ
Shares Held
28,568
-7.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#227
of 1,031 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Derivatives in BIIB

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$907,452
PutShares
4,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Baader Bank Aktiengesellschaft holds $38,581,797 across 9 Drug Manufacturers - General names. BIIB ranks #3 (16.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BIIB
Biogen Inc.
This page
28,568 $6,172,402

All Filings in BIIB

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,172,402 28,568
2026-06-30 $907,452 4,200
2026-03-31 $5,646,747 30,801
2026-03-31 $751,653 4,100
2025-12-31 $5,718,091 32,491
2025-09-30 $1,148,656 8,200
2025-09-30 $7,840,837 55,974